Skip to main content

Ogilvy Health’s Shannon Walsh selected as an ELITE Award Winner by PM360

Written by Customer Service on . Posted in Public Companies.

Shannon Walsh

Managing Director and PR Lead, Ogilvy Health

Managing Director and PR Lead, Ogilvy Health

NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) — Ogilvy Health announced today that Shannon Walsh, Managing Director and PR Lead, has been named to the prestigious 2021 ELITE list by healthcare marketing industry magazine PM360.

Now in its seventh year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today. The awards honor individuals who have made a significant impact in the life sciences field throughout their careers. Nominees are evaluated based on their accomplishments, testimonials from their clients and colleagues, and supporting evidence that reflects the impact of their efforts. Winners were selected in 19 categories from more than 500 entries extolling the merits and achievements of truly extraordinary individuals.

Shannon was recognized in the “PR Gurus” category, which honors communication experts who are masters at spreading news and good publicity.

Shannon shared, “It’s both humbling and an honor to be part of this year’s class of ELITE winners. I have always been passionate about the power of PR and the positive impact awareness and outreach can have when it comes to health. Being a member of the Ogilvy Health leadership team has afforded me the opportunity to affect real change in the lives of others. I can’t wait to see what the future holds for our clients and for the healthcare industry as a whole—now, more than ever before, it’s a very exciting time to be in this business.”

The PM360 ELITE winners are profiled in PM360’s May 2020 issue. For more information about this year’s winners, please visit: https://www.pm360online.com/the-2021-pm360-elite-100.

About Ogilvy Health
Ogilvy Health is focused on driving superior outcomes in the ever-changing healthcare environment, providing bespoke solutions for “whole brand building” in an increasingly complex and evolving marketplace. We believe in the power of making brands matter by keeping our audiences’ health and wellness needs at the center of every touchpoint. Our legacy of creativity, our global network, and our deep expertise allow us to apply diverse thinking to create solutions for client challenges. Ogilvy Health delivers insight, creativity, innovation, and engagement solutions for all healthcare stakeholders, patients, and consumers across the healthcare continuum—through Consulting, HCP Promotion, Market Access, Medical Education, Patient/Consumer Engagement, and PR and Influence—while also drawing on the full range of Ogilvy’s talent and capabilities to integrate Customer Engagement and Commerce, and Digital Transformation. Ogilvy is a WPP company (NYSE: WPP) (www.wpp.com). For more information, visit OgilvyHealth.com, or follow Ogilvy Health on Twitter, LinkedIn, Facebook, and Instagram.

Media Contacts:  Beth Paulino / beth.paulino@ogilvy.com
 Kerianne Slattery / kerianne.slattery@ogilvy.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/06416204-199d-4036-ae92-d61f3750e0b1

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.